Azemiglitazone

DB16028InvestigationalSmall molecule

Azemiglitazone is under investigation in clinical trial NCT01280695 (A Randomized, Double-blind, Comparator- and Placebo-controlled, Multiple-dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in...

Formula / weight: C₁₉H₁₇NO₅S · 371.41 g/mol (avg)
Code names: MSDC-0602

Resolves to

Compound

UNII81MXZ6QOBMCAS1133819-87-0ChEMBLCHEMBL4291468

Structure

InChIKeyYAUMOGALQJYOJQ-UHFFFAOYSA-NSMILESCOC1=CC=CC(=C1)C(=O)COC1=CC=C(CC2SC(=O)NC2=O)C=C1

Targets

P06213INSR

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Azemiglitazone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account